Assessing the pathogenicity of RYR1 variants in malignant hyperthermia

A. Merritt, P. Booms, M. A. Shaw, D. M. Miller, C. Daly, J. G. Bilmen, K. M. Stowell, P. D. Allen, D. S. Steele, P. M. Hopkins

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Background. Missense variants in the ryanodine receptor 1 gene (RYR1) are associated with malignant hyperthermia but only a minority of these have met the criteria for use in predictive DNA diagnosis. We examined the utility of a simplified method of segregation analysis and a functional assay for determining the pathogenicity of recurrent RYR1 variants associated with malignant hyperthermia. Methods.We identified previously uncharacterised RYR1 variants found in four or more malignant hyperthermia families and conducted simplified segregation analyses. An efficient cloning and mutagenesis strategy was used to express ryanodine receptor protein containing one of six RYR1 variants in HEK293 cells. Caffeine-induced calcium release, measured using a fluorescent calcium indicator, was compared in cells expressing each variant to that in cells expressing wild type ryanodine receptor protein. Results. We identified 43 malignant hyperthermia families carrying one of the six RYR1 variants. There was segregation of genotype with the malignant hyperthermia susceptibility phenotype in families carrying the p.E3104K and p.D3986E variants, but the number of informative meioses limited the statistical significance of the associations. HEK293 functional assays demonstrated an increased sensitivity of RyR1 channels containing the p.R2336H, p.R2355W, p.E3104K, p.G3990V and p.V4849I compared with wild type, but cells expressing p.D3986E had a similar caffeine sensitivity to cells expressing wild type RyR1. Conclusions. Segregation analysis is of limited value in assessing pathogenicity of RYR1 variants in malignant hyperthermia. Functional analyses in HEK293 cells provided evidence to support the use of p.R2336H, p.R2355W, p.E3104K, p.G3990V and p.V4849I for diagnostic purposes but not p.D3986E.

Original languageEnglish (US)
Pages (from-to)533-543
Number of pages11
JournalBritish Journal of Anaesthesia
Volume118
Issue number4
DOIs
StatePublished - Apr 1 2017

Keywords

  • Calcium signaling
  • Diagnosis
  • Genetics
  • HEK293 cells
  • Malignant hyperthermia
  • Malignant hyperthermia
  • Malignant hyperthermia
  • Physiopathology
  • RYR1

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Assessing the pathogenicity of RYR1 variants in malignant hyperthermia'. Together they form a unique fingerprint.

  • Cite this

    Merritt, A., Booms, P., Shaw, M. A., Miller, D. M., Daly, C., Bilmen, J. G., Stowell, K. M., Allen, P. D., Steele, D. S., & Hopkins, P. M. (2017). Assessing the pathogenicity of RYR1 variants in malignant hyperthermia. British Journal of Anaesthesia, 118(4), 533-543. https://doi.org/10.1093/bja/aex042